These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 14761919)
1. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma. Yamamoto S; Tomita Y; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K Ann Surg Oncol; 2004 Feb; 11(2):165-72. PubMed ID: 14761919 [TBL] [Abstract][Full Text] [Related]
2. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis. Yamamoto S; Tomita Y; Hoshida Y; Sakon M; Kameyama M; Imaoka S; Sekimoto M; Nakamori S; Monden M; Aozasa K Clin Cancer Res; 2004 Jan; 10(2):651-7. PubMed ID: 14760088 [TBL] [Abstract][Full Text] [Related]
3. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K J Clin Oncol; 2003 Jul; 21(13):2537-44. PubMed ID: 12829673 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer. Yamamoto S; Tomita Y; Uruno T; Hoshida Y; Qiu Y; Iizuka N; Nakamichi I; Miyauchi A; Aozasa K Ann Surg Oncol; 2005 Nov; 12(11):925-34. PubMed ID: 16189643 [TBL] [Abstract][Full Text] [Related]
5. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. Yamamoto S; Tomita Y; Nakamori S; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M; Aozasa K J Clin Oncol; 2003 Feb; 21(3):447-52. PubMed ID: 12560433 [TBL] [Abstract][Full Text] [Related]
6. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197 [TBL] [Abstract][Full Text] [Related]
7. Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma. Yamamoto S; Tomita Y; Hoshida Y; Toyosawa S; Inohara H; Kishino M; Kogo M; Nakazawa M; Murakami S; Iizuka N; Kidogami S; Monden M; Kubo T; Ijuhin N; Aozasa K Ann Oncol; 2004 Sep; 15(9):1432-8. PubMed ID: 15319251 [TBL] [Abstract][Full Text] [Related]
8. Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma. Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Monden M; Yamamoto S; Iuchi K; Aozasa K Ann Surg Oncol; 2004 Jul; 11(7):697-704. PubMed ID: 15231524 [TBL] [Abstract][Full Text] [Related]
9. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504 [TBL] [Abstract][Full Text] [Related]
10. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases. Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411 [TBL] [Abstract][Full Text] [Related]
11. Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Tsujimoto Y; Tomita Y; Hoshida Y; Kono T; Oka T; Yamamoto S; Nonomura N; Okuyama A; Aozasa K Clin Cancer Res; 2004 May; 10(9):3007-12. PubMed ID: 15131036 [TBL] [Abstract][Full Text] [Related]
12. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054 [TBL] [Abstract][Full Text] [Related]
13. Nectin-1 expression in cancer-associated fibroblasts is a predictor of poor prognosis for pancreatic ductal adenocarcinoma. Yamada M; Hirabayashi K; Kawanishi A; Hadano A; Takanashi Y; Izumi H; Kawaguchi Y; Mine T; Nakamura N; Nakagohri T Surg Today; 2018 May; 48(5):510-516. PubMed ID: 29256146 [TBL] [Abstract][Full Text] [Related]
14. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer. Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630 [TBL] [Abstract][Full Text] [Related]
16. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma. Zhao CY; Guo ZJ; Dai SM; Zhang Y; Zhou JJ Tumour Biol; 2013 Oct; 34(5):2983-7. PubMed ID: 23696030 [TBL] [Abstract][Full Text] [Related]
18. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma. Liu QH; Shi ML; Bai J; Zheng JN Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353 [TBL] [Abstract][Full Text] [Related]
19. Valosin-containing protein (VCP/p97)-expression correlates with prognosis of HPV- negative oropharyngeal squamous cell carcinoma (OSCC). Meyer MF; Seuthe IM; Drebber U; Siefer O; Kreppel M; Klein MO; Mikolajczak S; Klussmann JP; Preuss SF; Huebbers CU PLoS One; 2014; 9(12):e114170. PubMed ID: 25463965 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma. Sakugawa C; Haruyama Y; Tanaka H; Fukushima T; Kawaguchi M; Kataoka H BMC Res Notes; 2017 Dec; 10(1):674. PubMed ID: 29202869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]